DB-1310 suppressed tumor growth in a PDX model established with samples from osimertinib-resistant NSCLC patient harboring the EGFR Del19/T790M/C797S mutation (Fig. 5e). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.